5-MAPB: Difference between revisions

(2 intermediate revisions by one other user not shown)

Line 107:

*'''Luxembourg:''' 5-MAPB is not cited in the list of prohibited substances<ref>Loi du 19 février 1973 concernant la vente de substances médicamenteuses et la lutte contre la toxicomanie. | <nowiki>http://legilux.public.lu/eli/etat/leg/loi/1973/02/19/n1/jo</nowiki></ref>. Therefore, it is still a legal substance.

*'''Switzerland''': 5-MAPB is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>

*'''United Kingdom''': 5-MAPB is a Class B drug.<ref>UK Home Office (2014-03-05). "[https://www.legislation.gov.uk/ukdsi/2014/9780111110904 The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014]". UK Government. Retrieved 2014-03-11.</ref>

*'''United Kingdom''': 5-MAPB is a Class B drug.

*'''United States''': 5-MAPB could be considered an analogue of [[MDA]] and therefore would be covered under the Federal Analogue Act if intended for human consumption.

@@ Line 107: / Line 107: @@
 *'''Luxembourg:''' 5-MAPB is not cited in the list of prohibited substances<ref>Loi du 19 février 1973 concernant la vente de substances médicamenteuses et la lutte contre la toxicomanie. | <nowiki>http://legilux.public.lu/eli/etat/leg/loi/1973/02/19/n1/jo</nowiki></ref>. Therefore, it is still a legal substance.
 *'''Switzerland''': 5-MAPB is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
-*'''United Kingdom''': 5-MAPB is a Class B drug.<ref>UK Home Office (2014-03-05). "[https://www.legislation.gov.uk/ukdsi/2014/9780111110904 The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014]". UK Government. Retrieved 2014-03-11.</ref>
+*'''United Kingdom''': 5-MAPB is a Class B drug.
 *'''United States''': 5-MAPB could be considered an analogue of [[MDA]] and therefore would be covered under the Federal Analogue Act if intended for human consumption.